Literature DB >> 8675682

Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.

E M Bluman1, K J Bartynski, B R Avalos, M A Caligiuri.   

Abstract

Once infected by obligate intracellular pathogens, monocytes/macrophages release cytokines that activate natural killer (NK) cells. NK cells in turn produce and secrete monocyte/macrophage activating factors such as interferongamma (IFN-gamma), which are important in the early control of these infections. Here we demonstrate that human NK cells are potent producers of another monocyte/macrophage-activating factor, macrophage inflammatory protein-1 alpha (MIP-1 alpha). Fresh NK cells produce negligible amounts of MIP-1 alpha after stimulation with the monocyte-derived cytokines IL-12, TNF-alpha, IL-1 beta, or IL-10, while stimulation with IL-15 alone results in modest MIP-1 alpha production. Abundant NK cell production MIP-1 alpha is seen after costimulation with IL-12 and IL-15, and is dose-dependent. Combinations of IL-12, with TNF-alpha, IL-1 beta, or IL-10 are substantially less effective inducers of MIP-1 alpha production by NK cells. NK cell MIP-1 alpha mRNA transcripts were detectable within 1 h after costimulation with IL-12 plus IL-15 and steadily increased over 24 h, with a concomitant increase in protein production detectable at 12 h. Resting NK cells constitutively express mRNA transcript for a MIP-1 alpha receptor, and costimulation with IL-12 and IL-15 upregulates its level of expression. Equilibrium binding studies with radioiodinated MIP-1 alpha were consistent with the induction of a single class of high affinity MIP-1 alpha receptors on NK cells costimulated with IL-12 and IL-15. Addition of exogenous MIP-1 alpha to resting NK cells did not enhance cytokine production, but did increase NK cytotoxic activity. The requirement for IL-15 as a critical cofactor for NK cell production MIP-1 alpha suggests a potentially unique role for this monocyte-derived cytokine in combination with IL-12. As MIP-1 alpha is known to potentiate the action of IFN-gamma on monocytes and to suppress human immunodeficiency virus replication, the NK cell's production of MIP-1 alpha may be important during the innate immune response to infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675682      PMCID: PMC507364          DOI: 10.1172/JCI118726

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.

Authors:  W E Carson; M E Ross; R A Baiocchi; M J Marien; N Boiani; K Grabstein; M A Caligiuri
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

2.  Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice.

Authors:  H Heremans; C Dillen; J van Damme; A Billiau
Journal:  Eur J Immunol       Date:  1994-05       Impact factor: 5.532

Review 3.  The role of natural killer cells in innate resistance to infection.

Authors:  G J Bancroft
Journal:  Curr Opin Immunol       Date:  1993-08       Impact factor: 7.486

4.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Authors:  C S Tripp; S F Wolf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.

Authors:  J H Gong; G Maki; H G Klingemann
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

6.  Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10.

Authors:  R A Baiocchi; M E Ross; J C Tan; C C Chou; L Sullivan; S Haldar; M Monne; M V Seiden; S K Narula; J Sklar
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

7.  C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.

Authors:  A A Maghazachi; A al-Aoukaty; T J Schall
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

8.  The active monomeric form of macrophage inflammatory protein-1 alpha interacts with high- and low-affinity classes of receptors on human hematopoietic cells.

Authors:  B R Avalos; K J Bartynski; P J Elder; M S Kotur; W G Burton; N M Wilkie
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

9.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Authors:  W E Carson; J G Giri; M J Lindemann; M L Linett; M Ahdieh; R Paxton; D Anderson; J Eisenmann; K Grabstein; M A Caligiuri
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells.

Authors:  T Nakarai; M J Robertson; M Streuli; Z Wu; T L Ciardelli; K A Smith; J Ritz
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  34 in total

1.  Do beta-chemokines have clinical relevance in HIV infection?

Authors:  C E Mackewicz; E Barker; G Greco; G Reyes-Teran; J A Levy
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.

Authors:  Elizabeth L McMichael; Alena Cristina Jaime-Ramirez; Kristan D Guenterberg; Eric Luedke; Lakhvir S Atwal; Amanda R Campbell; Zhiwei Hu; Armika S Tatum; Sri Vidya Kondadasula; Xiaokui Mo; Susheela Tridandapani; Mark Bloomston; E Christopher Ellison; Terence M Williams; Tanios Bekaii-Saab; William E Carson
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

3.  Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.

Authors:  Elizabeth L McMichael; Nicholas B Courtney; Megan C Duggan; Robert Wesolowski; Dionisia Quiroga; Sri Vidya Kondadasula; Lakhvir S Atwal; Neela Bhave; Eric Luedke; Alena Cristina Jaime-Ramirez; Amanda R Campbell; Xiaokui Mo; John C Byrd; William E Carson Iii
Journal:  Oncoimmunology       Date:  2017-05-02       Impact factor: 8.110

4.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

Authors:  Cyril Fauriat; Eric O Long; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Blood       Date:  2009-12-01       Impact factor: 22.113

5.  MIP-3alpha, MIP-3beta and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells.

Authors:  A Al-Aoukaty; B Rolstad; A Giaid; A A Maghazachi
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

6.  Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes.

Authors:  D Haller; P Serrant; D Granato; E J Schiffrin; S Blum
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

7.  Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection.

Authors:  Michael D Parkes; Philip F Halloran; Luis G Hidalgo
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

8.  Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver.

Authors:  Thais P Salazar-Mather; Casey A Lewis; Christine A Biron
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12.

Authors:  Teddy F Mselle; Alexandra L Howell; Mimi Ghosh; Charles R Wira; Charles L Sentman
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

10.  Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses.

Authors:  Santanu Bose; Niladri Kar; Ratan Maitra; Joseph A DiDonato; Amiya K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.